reference/18858904

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18858904

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1477
issn	1540-9538 0022-1007
issueIdentifier	8
pageRange	1459-1477
publicationName	The Journal of experimental medicine
startingPage	1459
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_65fb47dd037c24fd30596e3a1df525f1 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_32b0a1cd7ae99f4ee32fe74686570a89
bibliographicCitation	Sashida G, Wang C, Tomioka T, Oshima M, Aoyama K, Kanai A, Mochizuki-Kashio M, Harada H, Shimoda K, Iwama A. The loss of Ezh2 drives the pathogenesis of myelofibrosis and sensitizes tumor-initiating cells to bromodomain inhibition. J Exp Med. 2016 Jul 25;213(8):1459–77. PMID: 27401345; PMCID: PMC4986523.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1041f2e022fa000ff86cf39e08917b70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6719-2444 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39068f7ea5e52b9f503b3f892e73f56a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11217663af4ea3117068f9ad664cb1a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_692f9f69a52af23976323f000277fd93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2136-4562 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7525-0851 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5586fd3f5ac0527bde615660d636d560 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3963-0013 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2318-5987
date	2016-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/27401345 https://pubmed.ncbi.nlm.nih.gov/PMC4986523 https://doi.org/10.1084/jem.20151121
isPartOf	https://portal.issn.org/resource/ISSN/0022-1007 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4724 https://portal.issn.org/resource/ISSN/1540-9538
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	The loss of Ezh2 drives the pathogenesis of myelofibrosis and sensitizes tumor-initiating cells to bromodomain inhibition
discusses	http://id.nlm.nih.gov/mesh/M0203030 http://id.nlm.nih.gov/mesh/M0499463 http://id.nlm.nih.gov/mesh/M000613664 http://id.nlm.nih.gov/mesh/M0473786 http://id.nlm.nih.gov/mesh/M0476035 http://id.nlm.nih.gov/mesh/M0375725
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D053614Q000378 http://id.nlm.nih.gov/mesh/D000071221Q000172 http://id.nlm.nih.gov/mesh/D053614Q000235 http://id.nlm.nih.gov/mesh/D055728Q000473 http://id.nlm.nih.gov/mesh/D055728Q000378 http://id.nlm.nih.gov/mesh/D014411Q000473 http://id.nlm.nih.gov/mesh/D055728Q000235 http://id.nlm.nih.gov/mesh/D014411Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D063151Q000378 http://id.nlm.nih.gov/mesh/D020125 http://id.nlm.nih.gov/mesh/D019943 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D025743Q000096 http://id.nlm.nih.gov/mesh/D025743Q000235 http://id.nlm.nih.gov/mesh/D018345 http://id.nlm.nih.gov/mesh/D063151Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11133 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_54e32599939667ce8030f6c1725ceac0 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c3addd02e769f33d86f94bb13502ccd5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8561 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6629 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_436fb487bed7ae78da7045da41afa2d1

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14056

Total number of triples: 64.